Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Frontiers in Pharmacology
|
October 21, 2015
Cardiac cAMP: production, hydrolysis, modulation and detection
Cédric Boularan, Céline Gales
Cellular Signalling
|
March 4, 2014
Implications of non-canonical G-protein signaling for the immune system
Cédric Boularan, John H Kehrl
The Journal of Biological Chemistry
|
June 30, 2009
Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha
Julie Claudinon, Pauline Gonnord, Emilie Beslard, et al.
Journal of Vascular Research
|
July 24, 2007
Identification of differentially expressed genes in human varicose veins: involvement of matrix gla protein in extracellular matrix remodeling
Chrystelle Cario-Toumaniantz, Cédric Boularan, Leon J Schurgers, et al.
Cell
|
December 25, 2010
Meningococcus Hijacks a β2-adrenoceptor/β-Arrestin pathway to cross brain microvasculature endothelium
Mathieu Coureuil, Hervé Lécuyer, Mark G H Scott, et al.
Journal of Medicinal Chemistry
|
November 28, 2006
Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist
David Chatenet, Christophe Dubessy, Cédric Boularan, et al.
Journal of Medicinal Chemistry
|
October 27, 2016
Design, Synthesis, and Biological Evaluation of Novel Cyclic Adenosine-Inosine Monophosphate (cAIMP) Analogs That Activate Stimulator of Interferon Genes (STING)
Thierry Lioux, Marc-Antoine Mauny, Alain Lamoureux, et al.
Nature Communications
|
July 17, 2014
A biosensor to monitor dynamic regulation and function of tumour suppressor PTEN in living cells
Evelyne Lima-Fernandes, Stanislas Misticone, Cédric Boularan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 7, 2007
beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53
Cédric Boularan, Mark G H Scott, Karima Bourougaa, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 5, 2016
Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor
Ségolène Galandrin, Colette Denis, Cédric Boularan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Frontiers in Pharmacology
|
October 21, 2015
Cardiac cAMP: production, hydrolysis, modulation and detection
Cédric Boularan, Céline Gales
Cellular Signalling
|
March 4, 2014
Implications of non-canonical G-protein signaling for the immune system
Cédric Boularan, John H Kehrl
The Journal of Biological Chemistry
|
June 30, 2009
Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha
Julie Claudinon, Pauline Gonnord, Emilie Beslard, et al.
Journal of Vascular Research
|
July 24, 2007
Identification of differentially expressed genes in human varicose veins: involvement of matrix gla protein in extracellular matrix remodeling
Chrystelle Cario-Toumaniantz, Cédric Boularan, Leon J Schurgers, et al.
Cell
|
December 25, 2010
Meningococcus Hijacks a β2-adrenoceptor/β-Arrestin pathway to cross brain microvasculature endothelium
Mathieu Coureuil, Hervé Lécuyer, Mark G H Scott, et al.
Journal of Medicinal Chemistry
|
November 28, 2006
Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist
David Chatenet, Christophe Dubessy, Cédric Boularan, et al.
Journal of Medicinal Chemistry
|
October 27, 2016
Design, Synthesis, and Biological Evaluation of Novel Cyclic Adenosine-Inosine Monophosphate (cAIMP) Analogs That Activate Stimulator of Interferon Genes (STING)
Thierry Lioux, Marc-Antoine Mauny, Alain Lamoureux, et al.
Nature Communications
|
July 17, 2014
A biosensor to monitor dynamic regulation and function of tumour suppressor PTEN in living cells
Evelyne Lima-Fernandes, Stanislas Misticone, Cédric Boularan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 7, 2007
beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53
Cédric Boularan, Mark G H Scott, Karima Bourougaa, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 5, 2016
Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor
Ségolène Galandrin, Colette Denis, Cédric Boularan, et al.
Page
of 2